Paeds management Flashcards
Down syndrome MDT
paediatrician
specialist nurse
PT + OT
SALT
SENCO
Down syndrome monitoring
echo
FBC + blood film
TFTs
hearing screening
GBS Rx
IV benpen + gentamicin
HDN Rx
resus
phototherapy
consider exchange transfusion
immune haemolytic -> IVIG
HDN follow up
4-6 weeks: late anaemia
hearing screen
hep B Rx
monovalent hep B vaccine <24hrs of birth
6-in-1 vaccine at usual times
HBIG if:
mum HbSag positive
acute hep B during pregnancy
DNA > 1x10^6 in any sample
acute: supportive care
HIE
supportive
ventilation
inotropic support
nutrition
seizure management
therapeutic hypothermia
mec aspiration
term + no Hx of GBS -> observe
RFs/labs suggestive of infection -> IV ampicillin + gentamicin
oxygen + NIV
surfactant + inotropes
NEC
TPN
NG tube
broad-spec abx
IV fluids
perforation/failure to respond -> surgery
asymptomatic neonatal hypoglycaemia
blood glucose
encourage feeding
supplemented feeding
symptomatic neonatal hypoglycaemia or pre-feed < 2mmol/L
2ml/kg 10% glucose IV bolus
3.6mL/lg/hr 10% glucose infusion
aim 3-4mmol/L
IV delay -> buccal glucose/IM glucagon
neonatal hypoglycaemia <1mmol/L
buccal glucose as interim while arranging IV glucose
persistent neonatal hypoglycaemia
refer to endo
neonatal jaundice Ix
transcutaneous
serum bilirubin
TSH, LFTs, split bilirubin
neonatal jaundice Rx
plot on graph
phototherapy
exchange transfusion
treat underlying cause
check for rebound jaundice
neonatal jaundice resource
NHS choices factsheet
breastfeeding network
bliss (premature/sick babies)
pneumothorax
small -> observe + 100% oxygen
immediate risk of resp failure -> needle drainage
tension/ventilated/preterm -> chest drain
RDS
resuscitation
intubation + ventilation
CPAP
supplementary oxygen (aim 91-95%)
endotracheal surfactant
fluids
broad spec IV abx
CXR
TTN
observe + supportive care
nasal cannula (aim >90%)
RR >60 -> NG/TPN
persists for >4-6hrs -> amp + gent
atrial septal defect
observe
closure at ~2 years
transcatheter/open heart surgery
indications for atrial septal defect closure
R heart enlargement
symptomatic pulmonary overcirculation
significant L - R shunting
congenital cyanotic heart disease initial Rx
A/B:
intubate
consider hyperoxia test
supplemental O2
C:
2 IV cannulae
consider UVC/UAC
prostaglandin E1 infusion
10ml/kg crystalloid bolus
adrenaline for resistant hypotension
D:
check blood glucose regularly
CoA
Prostaglandin E1
supportive
surgical repair
heart failure
reduce preload: diuretics
reduce after load: ACEi, alprostadil
enhance contractility: inotropes
nutrition
routine physical activity
PDA
IV indomethacin
prostacyclin synthesise inhibitor
premature/VLBW -> ibuprofen
surgical ligation
percutaneous catheter device closure
rheumatic fever
NSAIDs
anti-strep abx (pen V, benpen, amox)
heart failure -> diuretics + ACEi +/- pred
SVT
1st: vagal manoeuvres
2nd: adenosine
3rd: DC cardioversion
unstable -> DC cardioversion
ToF initial Rx
prostaglandin E1 infusion
Blalock-Taussig shunt between subclavian and pulmonary artery
ToF definitive Rx
surgical repair from 4 months onwards
hyper cyanotic spells
knee to chest position
supplementary O2
morphine (decrease respiratory drive)
IV fluids
beta blockers (relax RV, improve flow to pulmonary vessels)
phenylephrine (increase PVR)
sodium bicarb (met acidosis)
TGA initial Rx
supportive
prostaglandin E1 infusion
balloon atrial septostomy (foramen ovale to create large ASD)
TGA definitive Rx
arterial switch in first 2 weeks of life
VSD
observe
consider prophylactic amoxicillin
large VSD
surgical correction (transvenous catheter/open)
diuretics
high calorie diet
acute otitis media
paracetamol/ibuprofen
decongestants/antihistamines not helpful
unwell/perforation/otorrhoea -> immediate amoxicillin, otherwise delayed
pen-allergic -> clari
acute epiglottitis
senior support
ENT/anaesthetics
blood cultures
IV ceftriaxone 7-10/7
consider supplemental O2, steroids, Adr
stable + extubated -> PO co-amox
acute epiglottitis prophylaxis
rifampicin (good gram -ive cover)
mild allergic rhinitis
allergen avoidance
consider nasal irrigation
1st line: intranasal antihistamines
PO non-sedating antihistamines
2nd line: intranasal chromone
mod/severe allergic rhinitis
continue previous Rx
1st: + intranasal corticosteroid
2nd: consider short course PO corticosteroids for 3-7/7
allergic rhinitis with poor response to therapy
nasal congestion -> intranasal decongestant (ephedrine)
rhinorrhoea -> intranasal anticholinergic (ipratropium)
asthma -> LTRA
follow up for allergic rhinitis
review in 2-4 weeks for consideration of step up Rx
asthma <5, long term Rx
1: SABA
2: + paediatric low dose ICS
3: + LTRA
4: stop LTRA + refer
asthma 5-16, long term Rx
1: SABA
2: + paed low dose ICS
3: + LTRA
4: stop LTRA, + LABA
5: switch to MART + paed low dose ICS
6: increase ICS
7: consult specialist
asthma non-pharmacological Rx
assess baseline
education
action plan
immunisations
trigger avoidance
asthma review
confirm adherence
review technique
assess status
ask about triggers
PEFR asthma severity
> 50-75% = moderate
33-50% = severe
<33% = life-threatening
SpO2 asthma severity
> 92% = moderate
<92% severe/life-threatening
consciousness asthma severity
sentences = moderate
can’t complete sentences = severe
altered consciousness/confusion = life-threatening
HR/RR asthma severity
1-5 years:
moderate = <140, <40
severe = >140, >40
5+ years:
moderate = <125, <30
severe = >125, >30
signs of life-threatening asthma attack
silent chest
normal pCO2
poor respiratory effort
exhaustion
hypotension
cyanosis
acute life-threatening asthma attack Rx
admit, ABCDE, senior support
oxygen
salbutamol nebs (6L/min)
ipratropium nebs
mag sulphate (150mg)
prednisolone
monitor PEFR + sats
2nd line:
IV slabutamol
IV aminophylline
IV mag sulphate
acute moderate asthma exacerbation Rx
admit, ABCDE
oxygen
SABA via spacer
ipratroprium bromide
prednisolone
monitor PEFR + sats
prednisolone dose for asthma attack
1-2mg/kg/day PO OD
max 40mg/day
IM if oral not possible
acute asthma exacerbation follow up
admitted = <2 days of d/c
not admitted = <2 days of presentation
assess:
Sx
PEFR
inhaler technique
treatment
possible non-compliance
consider referral if >2 attacks <12 months
dxic Ix for bronchiectasis
high res CT:
bronchial wall thickening
signet ring
bronchiectasis general Rx
treat underlying cause
pneumococcal + influenza vax
bronchiectasis Ix for underlying cause
CF: sweat chloride test
antibody deficiency: IgG, A, M
primary ciliary dyskinesia
non CF bronchiectasis acute exacerbation Rx
airway clearance +/- saline nebs
abx
1st line abx for bronchiectasis
1month - 11yrs = amox, clari
12 - 17yrs = doxy
2nd line: co-amox
empirical IV abx for bronchiectasis
co-amox
pip-taz
cipro (seek specialist advice)
when to refer to secondary care in bronchiectasis
≥3 infective exacerbations in 1 year
severe infection
ineffective abx therapy
cardiorespiratory failure
sepsis
indications for admission in bronchiectasis
increased RR
increased WoB
cyanosis
circulatory/resp failure
temp ≥ 38
unable to take oral meds
bronchiectasis resources
British Lung Foundation patient info leaflet
Bronchiolitis Rx
humidified O2
CPAP
fluids
if secretions -> upper airway suction
Bronchiolitis prevention
infection control measures
Palivizumab
indications for admission in bronchiolitis
apnoea
central cyanosis
persistent low sats (<92% <6wks, <90% >6 wks)
50-75% reduced fluid intake
severe resp distress:
grunting
recessions
RR > 70
mild/moderate IgE/non-IgE mediated CMPA
allergy testing
paeds dietician referral
breastfeeding -> exclude cow’s milk from mother’s diet + calcium + vitamin d supplements
formula/mixed -> extensively hydrolysed formula
severe IgE mediated CMPA
as for mild/moderate
consider elemental formula
Sx of severe NON-IgE mediated CMPA
skin: pruritus, erythema, atopic eczema
GI: GORD, d&v, food aversion
Resp: cough, wheeze, SoB
severe NON-IgE mediated CMPA
interim Rx + urgent referral to local paeds allergy service + dietician
weaning in CMPA
reintroduce after 6 months then every 6-12 months
tolerance -> milk ladder from allergy UK
CMPA resources
British Dietetic Association fact sheet
All severities of croup Rx
0.15mg/kg PO dexamethasone
repeat after 12hrs if required
PO not possible:
2mg inhaled beclomethasone
0.6mg/kg IM dexamethasone
mild croup Rx
supportive care
safety net
moderate croup Rx
oxygen
severe croup Rx
admit
oxygen
adrenaline nebs (1 in 1000, 1mg/ml)
CF Rx
MDT approach
pulmonary: physio + mucolytics
infection: prophylactic abx
nutrition: high calorie + enzymes
psychosocial: support
CF mucoactive agents
1st line: rhDNase
2nd: hypertonic NaCl +/- frhDNase
3rd: mannitol dry powder
CF abx therapy
s. aureus prophylaxis -> fluclox
pseudomonas -> azithro, colistin
food allergy Rx
dietary:
exclude
dietician referral
pharm:
mild -> non-sedating antihistamine
severe -> IM adrenaline +/- salbutamol
educate:
action plan
epipen use
food challenge:
after 6-12 months Sx free
food challenge in food allergy
medical supervision
direct mucosal exposure
titrated oral ingestion as tolerated
previous severe reaction -> consider in hospital, usually after 2 years Sx free
prognosis of food allergies
milk and eggs - resolve early
nuts and seafood - persist
foreign body removal
1st line: flex/rigid bronchoscopy
2nd line: surgery, thoracotomy
pharm Rx of pneumonia
low/moderate -> amox, clari
severe -> co-amox +/- clari
PO if tolerated
scarlet fever Rx
notifiable disease
pen V QDS 10/7
pen allergic -> azithro
school exclusion until 24hrs after commencing abx
safety net + follow up
sinusitis Rx
< 10/7 -> do not offer abx
> 10/7 -> high dose nasal corticosteroid for 14/7
consider delayed abx
1st line: pen V
2nd line: co-amox
indications for admission in pharyngitis/tonsillitis
difficulty breathing
clinical dehydration
abscess/cellulitis
systemic illness/sepsis